1. Academic Validation
  2. Effect of opioid receptor antagonist on mitigating tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-induced apoptolysis in pemphigus pathogenesis

Effect of opioid receptor antagonist on mitigating tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-induced apoptolysis in pemphigus pathogenesis

  • J Autoimmun. 2024 Sep 13:149:103307. doi: 10.1016/j.jaut.2024.103307.
Xueting Peng 1 Sijia Wang 1 Kunyi Wu 2 Christopher Cook 3 Liang Li 4 Zhao Wang 1 Hanjiang Gu 1 Mei Lu 1 Guanglei Hu 1 Kaixuan Ren 1 Gang Hu 5 Weihui Zeng 1 Yumin Xia 6 Yale Liu 7
Affiliations

Affiliations

  • 1 Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi, China.
  • 2 Core Research Laboratory, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi, China.
  • 3 Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA.
  • 4 Department of Thoracic Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi, China.
  • 5 Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China.
  • 6 Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi, China. Electronic address: yuminxia@mail.xjtu.edu.cn.
  • 7 Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi, China. Electronic address: liuyale0703@xjtu.edu.cn.
Abstract

Pemphigus is a severe autoimmune blistering disease characterized by acantholysis triggered by autoantibodies against desmoglein 1 and 3 (DSG1/3). Apoptosis plays a pivotal role in facilitating acantholysis, yet the precise underlying mechanism remains obscure. Tumor necrosis factor-like weak inducer of Apoptosis (TWEAK) is known to promote Apoptosis and disrupt cell junctions, although its involvement in pemphigus pathogenesis remains ambiguous. Our study observed decreased DSG1/3 expression alongside increased TWEAK/fibroblast growth factor-inducible 14 (Fn14) expression and keratinocyte Apoptosis in both lesional and perilesional skin. In vitro experiments revealed that TWEAK-stimulated keratinocytes exhibited enhanced Apoptosis, STAT1 phosphorylation, and reduced intercellular DSG1/3 expression. Notably, bulk-RNA Sequencing unveiled that Caspase-3 was responsible for mediating the DSG1/3 depletion, as confirmed by direct interaction with DSG1/3 in a co-immunoprecipitation assay. Naloxone, known for preserving cellular adhesion and preventing cell death, effectively reduced Apoptosis and restored DSG1/3 levels in TWEAK-stimulated keratinocytes. The anti-apoptotic properties of naloxone were further validated in a murine pemphigus model. Our findings elucidate that TWEAK facilitates keratinocyte Apoptosis by augmenting Caspase-3 activity, leading to DSG1/3 depletion and Apoptosis in pemphigus. Importantly, naloxone can counter TWEAK-induced Apoptosis in pemphigus pathogenesis, offering a potential therapeutic intervention.

Keywords

Desmoglein; Naloxone; Pemphigus vulgaris; STAT1; TWEAK; apoptosis.

Figures
Products